(-)-anisomycin multiple interactions ISO RGD:731376 6480464 Anisomycin inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:16038797 (S)-nicotine decreases expression ISO RGD:731375 6480464 Nicotine results in decreased expression of CYP26A1 mRNA, Nicotine results in decreased expression of CYP26A1 protein CTD PMID:21371177 1,2-dichloroethane increases expression ISO RGD:731376 6480464 ethylene dichloride results in increased expression of CYP26A1 mRNA CTD PMID:28189721 , PMID:28960355 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP26A1 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:731375 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYP26A1 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:17404688 , PMID:20660070 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:731376 6480464 [Promegestone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:16955405 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:731375 6480464 [Retinaldehyde co-treated with Dihydrotestosterone] results in increased expression of CYP26A1 mRNA CTD PMID:17526768 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:731376 6480464 2 more ... CTD PMID:31449830 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:731376 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:31449830 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:731375 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731376 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26A1 mRNA CTD PMID:19770486 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731376 6480464 [Tetrachlorodibenzodioxin affects the methylation of CYP26A1 intron] which results in increased expression of CYP26A1 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP26A1 gene] CTD PMID:28213091 , PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731376 6480464 Tetrachlorodibenzodioxin affects the expression of CYP26A1 mRNA CTD PMID:28922406 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CYP26A1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CYP26A1 mRNA CTD PMID:21346803 2-Ethylhexanoic acid decreases expression ISO RGD:731376 6480464 2-ethylhexanoic acid results in decreased expression of CYP26A1 mRNA CTD PMID:30578912 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:731375 6480464 tetrabromobisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:33476716 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP26A1 mRNA CTD PMID:23358152 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CYP26A1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:731376 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CYP26A1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:731376 6480464 bis4-hydroxyphenylsulfone results in increased expression of CYP26A1 mRNA CTD PMID:30951980 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid multiple interactions ISO RGD:731375 6480464 Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CYP26A1 mRNA] CTD PMID:10953040 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:731375 6480464 Am 580 results in increased expression of CYP26A1 mRNA CTD PMID:10953040 4-hydroxyphenyl retinamide increases expression ISO RGD:731375 6480464 Fenretinide results in increased expression of CYP26A1 mRNA CTD PMID:15291358 4-hydroxyphenyl retinamide increases expression ISO RGD:731376 6480464 Fenretinide results in increased expression of CYP26A1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:731375 6480464 Decitabine affects the expression of CYP26A1 mRNA CTD PMID:23300844 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:731376 6480464 [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of CYP26A1 mRNA CTD PMID:27693483 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:731376 6480464 6-chloro-2 more ... CTD PMID:29990529 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP26A1 mRNA CTD PMID:24780913 9-cis-retinoic acid increases expression ISO RGD:731376 6480464 Alitretinoin results in increased expression of CYP26A1 mRNA CTD PMID:16688765 9-cis-retinoic acid increases expression ISO RGD:731375 6480464 Alitretinoin results in increased expression of CYP26A1 mRNA CTD PMID:16194896 acetamide increases expression EXP 6480464 acetamide results in increased expression of CYP26A1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:731375 6480464 Aflatoxin B1 results in increased expression of CYP26A1 mRNA CTD PMID:21641981 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP26A1 mRNA CTD PMID:33354967 aldrin increases expression ISO RGD:731375 6480464 Aldrin results in increased expression of CYP26A1 mRNA CTD PMID:15589975 aldrin multiple interactions ISO RGD:731375 6480464 AGN 193109 inhibits the reaction [Aldrin results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 all-trans-4-hydroxyretinoic acid multiple interactions ISO RGD:731375 6480464 [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-hydroxyretinoic acid more ... CTD PMID:12091498 , PMID:25492813 all-trans-4-hydroxyretinoic acid increases expression ISO RGD:731375 6480464 4-hydroxyretinoic acid results in increased expression of CYP26A1 mRNA CTD PMID:25492813 all-trans-4-hydroxyretinoic acid increases metabolic processing ISO RGD:731375 6480464 CYP26A1 protein results in increased metabolism of 4-hydroxyretinoic acid CTD PMID:25492813 all-trans-4-hydroxyretinoic acid increases chemical synthesis ISO RGD:731375 6480464 CYP26A1 mRNA results in increased chemical synthesis of 4-hydroxyretinoic acid, CYP26A1 protein results in increased chemical synthesis of 4-hydroxyretinoic acid CTD PMID:12091498 more ... all-trans-4-oxoretinoic acid increases chemical synthesis ISO RGD:731375 6480464 CYP26A1 mRNA results in increased chemical synthesis of 4-oxoretinoic acid, CYP26A1 protein results in increased chemical synthesis of 4-oxoretinoic acid CTD PMID:12091498 more ... all-trans-4-oxoretinoic acid increases expression ISO RGD:731375 6480464 4-oxoretinoic acid results in increased expression of CYP26A1 mRNA CTD PMID:25492813 all-trans-4-oxoretinoic acid increases metabolic processing ISO RGD:731375 6480464 CYP26A1 mRNA results in increased metabolism of 4-oxoretinoic acid, CYP26A1 protein results in increased metabolism of 4-oxoretinoic acid CTD PMID:12091498 , PMID:25492813 all-trans-4-oxoretinoic acid multiple interactions ISO RGD:731375 6480464 [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-oxoretinoic acid more ... CTD PMID:12091498 , PMID:25492813 all-trans-4-oxoretinol affects chemical synthesis ISO RGD:731376 6480464 CYP26A1 protein affects the chemical synthesis of 4-oxoretinol CTD PMID:10557354 all-trans-retinal multiple interactions ISO RGD:731375 6480464 [Retinaldehyde co-treated with Dihydrotestosterone] results in increased expression of CYP26A1 mRNA CTD PMID:17526768 all-trans-retinal increases expression ISO RGD:731375 6480464 Retinaldehyde results in increased expression of CYP26A1 mRNA CTD PMID:17526768 all-trans-retinoic acid increases expression ISO RGD:731376 6480464 Tretinoin results in increased expression of CYP26A1, Tretinoin results in increased expression of CYP26A1 mRNA CTD PMID:10862743 more ... all-trans-retinoic acid increases expression ISO RGD:731375 6480464 Tretinoin metabolite results in increased expression of CYP26A1 mRNA, Tretinoin results in increased expression of CYP26A1 mRNA CTD PMID:10953040 more ... all-trans-retinoic acid decreases abundance ISO RGD:731375 6480464 CYP26A1 protein results in decreased abundance of Tretinoin CTD PMID:18059332 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP26A1 mRNA CTD PMID:17185629 more ... all-trans-retinoic acid increases metabolic processing ISO RGD:731375 6480464 CYP26A1 mRNA results in increased metabolism of Tretinoin more ... CTD PMID:12091498 more ... all-trans-retinoic acid increases metabolic processing ISO RGD:731376 6480464 CYP26A1 protein results in increased metabolism of Tretinoin CTD PMID:19010342 all-trans-retinoic acid increases degradation ISO RGD:731376 6480464 CYP26A1 protein results in increased degradation of Tretinoin CTD PMID:12588859 all-trans-retinoic acid decreases response to substance ISO RGD:731376 6480464 CYP26A1 protein results in decreased susceptibility to Tretinoin CTD PMID:12588859 all-trans-retinoic acid affects degradation ISO RGD:731376 6480464 CYP26A1 protein affects the degradation of Tretinoin CTD PMID:16688765 all-trans-retinoic acid multiple interactions ISO RGD:731376 6480464 [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of CYP26A1 mRNA more ... CTD PMID:12588859 more ... all-trans-retinoic acid multiple interactions ISO RGD:731375 6480464 2 more ... CTD PMID:12091498 more ... all-trans-retinoic acid decreases metabolic processing ISO RGD:731375 6480464 CYP26A1 exon SNP results in decreased metabolism of Tretinoin, CYP26A1 protein polymorphism results in decreased metabolism of Tretinoin CTD PMID:17460545 all-trans-retinoic acid multiple interactions EXP 6480464 [R 115866 results in decreased activity of CYP26A1 protein] which results in increased abundance of Tretinoin, Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:17185629 , PMID:17510468 all-trans-retinol multiple interactions ISO RGD:731375 6480464 [Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA CTD PMID:17244623 all-trans-retinol increases expression ISO RGD:731376 6480464 Vitamin A results in increased expression of CYP26A1 mRNA CTD PMID:30944279 all-trans-retinol increases expression ISO RGD:731375 6480464 Vitamin A results in increased expression of CYP26A1 mRNA CTD PMID:16194896 , PMID:22542753 all-trans-retinol multiple interactions EXP 6480464 [R 115866 co-treated with Vitamin A] results in increased expression of CYP26A1 mRNA CTD PMID:17510468 all-trans-retinol affects metabolic processing ISO RGD:731376 6480464 CYP26A1 protein affects the metabolism of Vitamin A CTD PMID:10557354 amiodarone increases expression ISO RGD:731375 6480464 Amiodarone results in increased expression of CYP26A1 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP26A1 mRNA CTD PMID:16483693 aphidicolin increases expression ISO RGD:731376 6480464 Aphidicolin results in increased expression of CYP26A1 mRNA CTD PMID:29990529 arotinoid acid multiple interactions ISO RGD:731375 6480464 AGN 193109 inhibits the reaction [4-2-5 more ... CTD PMID:15589975 arotinoid acid increases expression ISO RGD:731375 6480464 4-2-5 more ... CTD PMID:15589975 arsane multiple interactions ISO RGD:731375 6480464 Arsenic affects the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:18288313 arsenic atom multiple interactions ISO RGD:731375 6480464 Arsenic affects the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:18288313 arsenous acid multiple interactions ISO RGD:731376 6480464 Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:15688020 belinostat increases expression ISO RGD:731375 6480464 belinostat results in increased expression of CYP26A1 mRNA CTD PMID:26272509 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of CYP26A1 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:731375 6480464 Benzoapyrene affects the methylation of CYP26A1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:731376 6480464 Benzoapyrene results in increased expression of CYP26A1 mRNA CTD PMID:32417428 beta-carotene increases expression ISO RGD:731375 6480464 beta Carotene results in increased expression of CYP26A1 mRNA CTD PMID:16186334 , PMID:22542753 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP26A1 mRNA CTD PMID:18164116 bexarotene increases expression ISO RGD:731375 6480464 bexarotene results in increased expression of CYP26A1 mRNA CTD PMID:17178900 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CYP26A1 mRNA CTD PMID:17630414 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731376 6480464 Diethylhexyl Phthalate results in increased expression of CYP26A1 mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:731375 6480464 Diethylhexyl Phthalate results in decreased expression of CYP26A1 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter CTD PMID:23359474 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter CTD PMID:23359474 bisphenol A increases expression ISO RGD:731376 6480464 bisphenol A results in increased expression of CYP26A1 mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:731376 6480464 bisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:31288075 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP26A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:731375 6480464 bisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:33476716 bisphenol F decreases expression ISO RGD:731375 6480464 bisphenol F results in decreased expression of CYP26A1 mRNA CTD PMID:33476716 bisphenol F increases expression ISO RGD:731376 6480464 bisphenol F results in increased expression of CYP26A1 mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CYP26A1 mRNA CTD PMID:32479839 butanal increases expression ISO RGD:731375 6480464 butyraldehyde results in increased expression of CYP26A1 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO RGD:731376 6480464 Cadmium results in decreased expression of CYP26A1 mRNA CTD PMID:19556237 calciol increases expression ISO RGD:731376 6480464 Cholecalciferol results in increased expression of CYP26A1 mRNA CTD PMID:17170073 calcitriol increases expression ISO RGD:731375 6480464 Calcitriol results in increased expression of CYP26A1 mRNA CTD PMID:27107558 carbamazepine affects expression ISO RGD:731375 6480464 Carbamazepine affects the expression of CYP26A1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:731376 6480464 Nanotubes more ... CTD PMID:25620056 ciguatoxin CTX1B affects expression ISO RGD:731376 6480464 Ciguatoxins affects the expression of CYP26A1 mRNA CTD PMID:18353800 ciprofibrate decreases expression ISO RGD:731376 6480464 ciprofibrate results in decreased expression of CYP26A1 mRNA CTD PMID:12771043 cisplatin affects expression ISO RGD:731375 6480464 Cisplatin affects the expression of CYP26A1 mRNA CTD PMID:23300844 cisplatin decreases response to substance ISO RGD:731375 6480464 CYP26A1 protein results in decreased susceptibility to Cisplatin CTD PMID:15703382 clofibrate decreases expression ISO RGD:731376 6480464 Clofibrate results in decreased expression of CYP26A1 mRNA CTD PMID:17585979 cocaine affects expression EXP 6480464 Cocaine affects the expression of CYP26A1 mRNA CTD PMID:20187946 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP26A1 mRNA CTD PMID:22664269 diarsenic trioxide multiple interactions ISO RGD:731376 6480464 Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:15688020 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter CTD PMID:23359474 diclofenac decreases expression ISO RGD:731376 6480464 Diclofenac results in decreased expression of CYP26A1 mRNA CTD PMID:26934552 dieldrin multiple interactions ISO RGD:731375 6480464 AGN 193109 inhibits the reaction [Dieldrin results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 dieldrin increases expression ISO RGD:731375 6480464 Dieldrin results in increased expression of CYP26A1 mRNA CTD PMID:15589975 diethylstilbestrol decreases expression ISO RGD:731376 6480464 Diethylstilbestrol results in decreased expression of CYP26A1 mRNA CTD PMID:29990529 dorsomorphin multiple interactions ISO RGD:731375 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 endosulfan multiple interactions ISO RGD:731375 6480464 AGN 193109 inhibits the reaction [Endosulfan results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CYP26A1 mRNA CTD PMID:29391264 endosulfan increases expression ISO RGD:731375 6480464 Endosulfan results in increased expression of CYP26A1 mRNA CTD PMID:15589975 , PMID:26615145 endrin increases expression ISO RGD:731375 6480464 Endrin results in increased expression of CYP26A1 mRNA CTD PMID:15589975 endrin multiple interactions ISO RGD:731375 6480464 AGN 193109 inhibits the reaction [Endrin results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 entinostat increases expression ISO RGD:731375 6480464 entinostat results in increased expression of CYP26A1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:731375 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP26A1 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:731376 6480464 Ethanol results in increased expression of CYP26A1 mRNA CTD PMID:19167417 etoposide decreases response to substance ISO RGD:731375 6480464 CYP26A1 protein results in decreased susceptibility to Etoposide CTD PMID:15703382 fenarimol increases expression EXP 6480464 fenarimol results in increased expression of CYP26A1 mRNA CTD PMID:28970091 fipronil increases expression ISO RGD:731375 6480464 fipronil results in increased expression of CYP26A1 mRNA CTD PMID:27091632 fipronil multiple interactions ISO RGD:731375 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26A1 mRNA CTD PMID:27091632 fluconazole increases expression ISO RGD:731376 6480464 Fluconazole results in increased expression of CYP26A1 mRNA CTD PMID:19429397 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CYP26A1 mRNA CTD PMID:22664269 more ... fonofos increases methylation ISO RGD:731375 6480464 Fonofos results in increased methylation of CYP26A1 promoter CTD PMID:22847954 Heptachlor epoxide increases expression ISO RGD:731376 6480464 Heptachlor Epoxide results in increased expression of CYP26A1 mRNA CTD PMID:25270620 hexadecanoic acid multiple interactions ISO RGD:731375 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26A1 mRNA CTD PMID:30547786 hydrogen peroxide multiple interactions ISO RGD:731375 6480464 CYP26A1 protein inhibits the reaction [[Tretinoin co-treated with Hydrogen Peroxide] results in increased expression of CDKN1A protein] more ... CTD PMID:15703382 hydrogen peroxide decreases response to substance ISO RGD:731375 6480464 CYP26A1 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:15703382 hydroxyurea increases expression ISO RGD:731376 6480464 Hydroxyurea results in increased expression of CYP26A1 mRNA CTD PMID:29990529 isotretinoin increases expression ISO RGD:731375 6480464 Isotretinoin results in increased expression of CYP26A1 mRNA CTD PMID:16194896 more ... ketoconazole multiple interactions ISO RGD:731375 6480464 [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-hydroxyretinoic acid more ... CTD PMID:12091498 more ... ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CYP26A1 mRNA CTD PMID:28263823 ketoconazole decreases response to substance ISO RGD:731375 6480464 Ketoconazole results in decreased susceptibility to CYP26A1 protein CTD PMID:18059332 ketoconazole decreases activity ISO RGD:731375 6480464 Ketoconazole results in decreased activity of CYP26A1, Ketoconazole results in decreased activity of CYP26A1 protein CTD PMID:14532297 , PMID:25492813 liarozole multiple interactions ISO RGD:731375 6480464 [liarozole co-treated with Tretinoin] results in increased expression of CYP26A1 mRNA, liarozole promotes the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:21428449 , PMID:21838328 liarozole decreases activity ISO RGD:731375 6480464 liarozole results in decreased activity of CYP26A1 protein CTD PMID:15597402 , PMID:16279770 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:17185629 lithocholic acid multiple interactions ISO RGD:731375 6480464 Lithocholic Acid promotes the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:18059332 lithocholic acid increases expression ISO RGD:731375 6480464 Lithocholic Acid results in increased expression of CYP26A1 mRNA CTD PMID:18059332 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP26A1 mRNA CTD PMID:23358152 methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of CYP26A1 mRNA CTD PMID:20864626 methylmercury chloride increases expression ISO RGD:731375 6480464 methylmercuric chloride results in increased expression of CYP26A1 mRNA CTD PMID:23179753 more ... microcystin-LR decreases expression ISO RGD:731376 6480464 cyanoginosin LR results in decreased expression of CYP26A1 mRNA CTD PMID:17383702 Monobutylphthalate affects expression ISO RGD:731376 6480464 monobutyl phthalate affects the expression of CYP26A1 mRNA CTD PMID:19162170 N,N-diethyl-m-toluamide multiple interactions ISO RGD:731375 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26A1 mRNA CTD PMID:27091632 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:731375 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CYP26A1 mRNA CTD PMID:31806706 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP26A1 mRNA CTD PMID:18164116 N-nitrosodiethylamine decreases expression ISO RGD:731376 6480464 Diethylnitrosamine results in decreased expression of CYP26A1 mRNA CTD PMID:12771043 , PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CYP26A1 mRNA CTD PMID:25380136 nicotine decreases expression ISO RGD:731375 6480464 Nicotine results in decreased expression of CYP26A1 mRNA, Nicotine results in decreased expression of CYP26A1 protein CTD PMID:21371177 Nonylphenol increases expression ISO RGD:731376 6480464 nonylphenol results in increased expression of CYP26A1 mRNA CTD PMID:31288075 oleic acid multiple interactions ISO RGD:731375 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA, [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26A1 mRNA CTD PMID:30547786 paracetamol affects expression ISO RGD:731376 6480464 Acetaminophen affects the expression of CYP26A1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:731375 6480464 Acetaminophen results in decreased expression of CYP26A1 mRNA CTD PMID:21420995 parathion increases methylation ISO RGD:731375 6480464 Parathion results in increased methylation of CYP26A1 promoter CTD PMID:22847954 pentanal increases expression ISO RGD:731375 6480464 pentanal results in increased expression of CYP26A1 mRNA CTD PMID:26079696 phenobarbital increases expression ISO RGD:731376 6480464 Phenobarbital results in increased expression of CYP26A1 mRNA CTD PMID:19270015 more ... phenylmercury acetate multiple interactions ISO RGD:731375 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CYP26A1 mRNA CTD PMID:27188386 piperonyl butoxide increases expression ISO RGD:731376 6480464 Piperonyl Butoxide results in increased expression of CYP26A1 mRNA CTD PMID:30572783 pirinixic acid multiple interactions ISO RGD:731376 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP26A1 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:731376 6480464 pirinixic acid results in decreased expression of CYP26A1 mRNA CTD PMID:23811191 potassium dichromate decreases expression ISO RGD:731376 6480464 Potassium Dichromate results in decreased expression of CYP26A1 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:731376 6480464 Pregnenolone Carbonitrile results in increased expression of CYP26A1 mRNA CTD PMID:28903501 progesterone multiple interactions ISO RGD:731375 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYP26A1 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:17404688 , PMID:20660070 progesterone affects expression ISO RGD:731376 6480464 Progesterone affects the expression of CYP26A1 mRNA CTD PMID:17251523 progesterone multiple interactions ISO RGD:731376 6480464 [Progesterone results in increased activity of PGR protein] which results in increased expression of CYP26A1 mRNA CTD PMID:15845616 progesterone increases expression ISO RGD:731375 6480464 Progesterone results in increased expression of CYP26A1 mRNA CTD PMID:17404688 promegestone increases expression ISO RGD:731376 6480464 Promegestone results in increased expression of CYP26A1 mRNA CTD PMID:16955405 promegestone multiple interactions ISO RGD:731376 6480464 [Promegestone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:16955405 propanal increases expression ISO RGD:731375 6480464 propionaldehyde results in increased expression of CYP26A1 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:731376 6480464 propiconazole results in increased expression of CYP26A1 mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP26A1 mRNA CTD PMID:28970091 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP26A1 mRNA CTD PMID:23358152 raloxifene decreases expression ISO RGD:731376 6480464 Raloxifene Hydrochloride results in decreased expression of CYP26A1 mRNA CTD PMID:29990529 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26A1 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO RGD:731376 6480464 6-chloro-2 more ... CTD PMID:29990529 , PMID:31298478 resveratrol increases expression ISO RGD:731376 6480464 Resveratrol results in increased expression of CYP26A1 mRNA CTD PMID:29990529 retinyl acetate multiple interactions ISO RGD:731376 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:16322074 , PMID:31449830 retinyl acetate increases expression ISO RGD:731376 6480464 retinol acetate results in increased expression of CYP26A1 mRNA CTD PMID:16322074 , PMID:31449830 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of CYP26A1 mRNA CTD PMID:18047727 rifampicin multiple interactions ISO RGD:731375 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP26A1 mRNA CTD PMID:21127053 Ro 41-5253 multiple interactions ISO RGD:731375 6480464 Ro 41-5253 inhibits the reaction [4-5 more ... CTD PMID:10953040 SB 431542 multiple interactions ISO RGD:731375 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:731375 6480464 Silicon Dioxide analog results in increased expression of CYP26A1 mRNA CTD PMID:25895662 sodium arsenite increases methylation ISO RGD:731376 6480464 sodium arsenite results in increased methylation of CYP26A1 gene CTD PMID:24118411 sodium arsenite increases expression ISO RGD:731375 6480464 sodium arsenite results in increased expression of CYP26A1 mRNA CTD PMID:28595984 sodium arsenite multiple interactions ISO RGD:731376 6480464 [Dietary Fats co-treated with sodium arsenite] results in decreased expression of CYP26A1 mRNA CTD PMID:28283972 sodium arsenite decreases expression ISO RGD:731376 6480464 sodium arsenite results in decreased expression of CYP26A1 mRNA CTD PMID:28283972 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26A1 mRNA CTD PMID:25905778 tamoxifen affects expression ISO RGD:731375 6480464 Tamoxifen affects the expression of CYP26A1 mRNA CTD PMID:14699072 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CYP26A1 mRNA CTD PMID:17630414 tamoxifen affects expression ISO RGD:731376 6480464 Tamoxifen affects the expression of CYP26A1 mRNA CTD PMID:20937368 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP26A1 mRNA CTD PMID:28970091 terbufos increases methylation ISO RGD:731375 6480464 terbufos results in increased methylation of CYP26A1 promoter CTD PMID:22847954 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP26A1 mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA CTD PMID:32741896 tetrachloromethane decreases expression ISO RGD:731376 6480464 Carbon Tetrachloride results in decreased expression of CYP26A1 mRNA CTD PMID:27339419 tetrachloromethane increases expression ISO RGD:731376 6480464 Carbon Tetrachloride results in increased expression of CYP26A1 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP26A1 mRNA CTD PMID:31150632 tetracycline decreases expression ISO RGD:731376 6480464 Tetracycline results in decreased expression of CYP26A1 mRNA CTD PMID:16917069 titanium dioxide decreases expression ISO RGD:731376 6480464 titanium dioxide results in decreased expression of CYP26A1 mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO RGD:731376 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP26A1 mRNA] CTD PMID:31298478 triadimefon increases expression ISO RGD:731376 6480464 triadimefon results in increased expression of CYP26A1 mRNA CTD PMID:19010342 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP26A1 mRNA CTD PMID:22664269 , PMID:28263823 tributylstannane increases expression ISO RGD:731376 6480464 tributyltin results in increased expression of CYP26A1 mRNA CTD PMID:31939706 trichloroethene decreases expression ISO RGD:731376 6480464 Trichloroethylene results in decreased expression of CYP26A1 mRNA CTD PMID:25055964 trichostatin A decreases expression ISO RGD:731375 6480464 trichostatin A results in decreased expression of CYP26A1 mRNA CTD PMID:24935251 trichostatin A increases expression ISO RGD:731375 6480464 trichostatin A results in increased expression of CYP26A1 mRNA CTD PMID:24935251 triptonide increases expression ISO RGD:731376 6480464 triptonide results in increased expression of CYP26A1 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP26A1 mRNA CTD PMID:21515302 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CYP26A1 mRNA CTD PMID:15885361 valproic acid decreases expression ISO RGD:731376 6480464 Valproic Acid results in decreased expression of CYP26A1 mRNA CTD PMID:19136453 more ... valproic acid increases methylation ISO RGD:731375 6480464 Valproic Acid results in increased methylation of CYP26A1 gene CTD PMID:29501571 valproic acid multiple interactions ISO RGD:731375 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of CYP26A1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:731375 6480464 Valproic Acid results in increased expression of CYP26A1 mRNA CTD PMID:26272509 valproic acid affects expression ISO RGD:731375 6480464 Valproic Acid affects the expression of CYP26A1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:731376 6480464 4-2-5 more ... CTD PMID:27693483 valproic acid affects expression ISO RGD:731376 6480464 Valproic Acid affects the expression of CYP26A1 mRNA CTD PMID:27693483 valproic acid decreases expression ISO RGD:731375 6480464 Valproic Acid results in decreased expression of CYP26A1 mRNA CTD PMID:23179753 more ... vorinostat decreases expression ISO RGD:731375 6480464 vorinostat results in decreased expression of CYP26A1 mRNA CTD PMID:27188386
